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ABSTRACT  
 
Staphylococcus aureus is an opportunistic pathogen and variable component of the human 
microbiota. In atopic eczema (AE) a characteristic of the disease is colonization by S. aureus, 
with exacerbations associated with an increased bacterial burden of the organism. Despite 
this, the origins and genetic diversity of S. aureus colonizing individual patients during AE 
disease flares is poorly understood. To examine the micro-evolution of S. aureus colonization 
we have deep-sequenced S. aureus populations from nine children with moderate to severe 
AE, and 18 non-atopic children asymptomatically carrying S. aureus nasally. Colonization by 
clonal S. aureus populations was observed in both AE cases and controls, with all but one of 
the individuals containing colonies belonging to a single sequence type. Phylogenetic analysis 
revealed that disease flares were associated with the clonal expansion of the S. aureus 
population, occurring over a period of weeks to months. There was a significant difference in 
the genetic backgrounds of S. aureus colonizing AE patients versus controls (Fisher’s Exact 
test, p=0.03). Examination of intra-host genetic heterogeneity of the colonizing S. aureus 
populations identified evidence of within-host selection in the AE patients, with AE variants 
being potentially selectively advantageous for intracellular persistence and treatment 
resistance. 
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INTRODUCTION  
Clinical studies have demonstrated a link between Staphylococcus aureus and the 
pathogenesis of atopic eczema (AE). Affected individuals are characteristically prone to 
colonization by this pathogen (Leyden et al. 1974; Hauser et al. 1985), with disease severity 
correlating to bacterial burden and number of colonized sites (Tauber et al. 2016). 
 
Increasingly there has been a shift towards understanding how cutaneous dysbiosis 
contributes to AE aetiology (Chng et al. 2016; Kennedy et al. 2016). Metagenomic analysis 
has shown that changes in populations of microbial communities are significantly associated 
with disease activity in AE, and that increased in S. aureus is linked to increasing severity 
(Kong et al. 2012). Whilst providing a more holistic overview of microbial population 
structure in AE, current metagenomic approaches have thus far failed to resolve the fine-scale 
population dynamics of S. aureus in AE, or the genetic changes occurring in the colonizing 
population of this versatile pathogen.  
 
Whole genome sequencing (WGS) is a high-resolution genotyping tool that can be used to 
study within host evolution and transmission. Deep sequencing studies of S. aureus 
populations have revealed heterogeneity arising within the host and the impact on the disease 
causing potential of the population (Young et al. 2012; Paterson et al. 2015; Azarian et al. 
2016). By using WGS to genetically characterize bacteria it is possible to investigate how 
populations differentiate and adapt within a host during colonization as well as reconstructing 
the evolutionary events shaping populations (Didelot et al. 2016). In this study we deep 
sequenced S. aureus populations from children with AE, enabling us to investigate the micro-
evolution of colonization during disease flare. From this we have uncovered evidence of 
selection enriching for colonization by S. aureus of specific genetic backgrounds, as well as 
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genetic diversification promoting the survival and persistence of these strains during 
colonization of AE patients.   
 
RESULTS  
S. aureus colonization in cases and controls 
Nine AE cases were recruited through Ninewells Hospital in Dundee, and skin swabs 
obtained from 5 body sites, including a nostril, 2 areas of inflamed eczema skin, and 2 
separate areas of clinically unaffected skin. All were colonized by S. aureus at one or more 
sampled sites. Eighteen community S. aureus nasal carriers were selected from the larger 
control study population, from whom swabs were taken from a single nostril. Extra-nasal skin 
swabs obtained from controls were in all instances negative for S. aureus. Control age 
matching was attempted but age-appropriate carriers identified had a history of atopy and 
were therefore excluded on this basis (Table 1).  
 
All cases had generalized moderate-to-severe eczema, the exception being patient 5, who had 
locally severe disease only (Table S1). Four of the nine cases (44%) were nasally colonized in 
addition to eczema-affected skin, whilst seven (78%) were also colonized on clinically 
unaffected skin. Bacterial burden varied across colonization sites within individuals, and also 
between individuals (Table S2). Where available, 5 colonies from the primary isolation plates 
were randomly selected per swabbed body site to provide representative sampling and detect 
co-colonization (Votintseva et al. 2014). In cases with low bacterial burden, fewer than 5 
colonies were available for WGS. Eczema site sub-sampling was included to investigate S. 
aureus population heterogeneity within disease sites. We undertook WGS of between 10 and 
28 colonies per AE case dependent on recovered colony counts.  
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AE patients are colonized with distinct clonal populations of S. aureus  
All controls, and all but one case, were colonized by clonal populations of S. aureus 
represented by a single sequence type (ST) defined by multilocus sequence typing (MLST) 
(Table S3). The exception, Patient 8, was co-colonized by two distinct STs. Comparison of 
the genetic backgrounds of the S. aureus colonizing populations in cases and controls 
revealed different ST distributions (Figure 1). Eczema cases were more frequently colonized 
with STs belonging to clonal complex (CC) 1; 4 of the 9 AE cases (44%) carried STs 
belonging to CC1 (ST1 and ST188), compared with a single control (6%; Fisher’s Exact test, 
p=0.03). Conversely, controls were principally colonized with CC30; 11 of the 18 controls 
(61%) carried STs belonging to CC30 (ST30 and ST2889), compared with one case (11%; 
Fisher’s Exact test, p=0.02). This suggested a subset of the S. aureus population is more 
frequently associated with colonization in AE. Overall, the proportions of CCs of isolates 
from cases and controls in revealed a significant difference in the distribution in CC of strains 
on the basis of disease status (Fisher’s Exact test; p=0.005). 
 
Clonal expansion of S. aureus populations in AE patients  
The observed clonal populations in cases suggest that during disease flare there is a clonal 
expansion within the host, i.e. the S. aureus growing on eczema skin originates from a small 
progenitor population within the individual. To provide a high-resolution view of the 
colonizing populations we characterized the genomic diversity of the isolates and examined 
their phylogenetic relationships. As a measure of the relative within-host diversities of S. 
aureus populations we examined the core genome of the sequenced isolates to identify single 
nucleotide polymorphisms (SNPs). The levels of diversity we observed in both cases and 
controls were comparable to previous studies examining the in-host population diversity of S. 
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aureus during carriage (maximum pairwise of SNP distance differentiating colonies from AE 
cases was 26, and in controls 17) (Golubchik et al. 2013; Tong et al. 2015). 
 
In AE cases where nasal colonization was detected, colonies derived from skin and nasal sites 
were interspersed throughout the phylogeny, suggesting exchange of S. aureus between sites 
rather than niche-specific populations (Figures 2a, S1). Comparison of the relative genetic 
diversities of populations from the different body sites in patient 1, revealed a significant 
difference in the pairwise SNP distance separating colonies from different body sites 
(Kruskal-Wallis rank sum test, p=3.9e-06; Figure 2b). Nasal isolates were distinguished by the 
greatest mean SNP distance per colony, suggesting that the S. aureus sampled from the 
patient’s nose had diversified over a longer period (Figure 2b). There was a significant 
difference in the pairwise SNP distance observed between nasal isolates and the eczema 1 
sub-sampling site isolates (Wilcoxon-Mann-Whitney test, p=0.015) but not compared with 
eczema 2 sub-site colonies (Wilcoxon-Mann-Whitney test, p=0.16). This demonstrates that 
there is genetic and spatial diversity even within a single sampled site. Conversely, the 
absence of diversity in S. aureus from unaffected skin suggests very recent colonization of the 
site or potential variable replication rates influenced by the nutrient availability in the 
differing colonization environment (Figure 2a). The distribution of nasal isolates throughout 
the phylogeny, including basally, and intermingling with eczema isolates, suggests the nasal 
carriage represented a more established population, and hence a potential source of S. aureus 
colonizing diseased skin, therefore representing self transmission. 
  
The S. aureus from AE cases and controls exhibited overlapping distributions of relative 
population diversities (cases 0.1-2.6 SNPs/colony/individual; controls 0.0-3.4 
SNPs/colony/individual) suggesting similar patterns of within-host diversification between 
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the two groups (Table S4), even though the sampling in the controls was limited to a single 
niche. Using previously calculated mutation rates for S. aureus we estimated the age of the 
sampled population for each participant. This suggested periods of 0 weeks to 37 months in 
cases, and from less than a week to 24 months in controls, for the population to have diverged 
from a common ancestor (Figure 3). 
 
Evidence of adaption in the colonizing population 
Diseased skin represents a physiologically distinct colonization environment compared to 
nasal epithelium, the primary carriage site of S. aureus in humans. We therefore hypothesized 
that the genomes of S. aureus from AE may exhibit evidence of environmental selection and 
adaption compared with controls. However, comparison of the distribution of mutation types 
between cases and controls did not show a significant difference in frequency of non-
synonymous, synonymous or intergenic SNPs (Chi squared test, p=0.74) (Figure S2a). 
Examining the functional distribution of non-synonymous mutations revealed several gene 
categories differentially represented between study populations but this was also not 
significant (Fisher’s Exact test, p=0.27) (Figure S2b). 
 
In the absence of signals of selection in AE cases at the cohort level, we looked for evidence 
of biologically and clinically relevant adaptation occurring in S. aureus at the patient level. 
Another source of variation in the S. aureus genome is in its content of mobile genetic 
elements (MGEs), which constitute the accessory genome (Lindsay and Holden 2006). Two 
instances of accessory genome diversification were identified in AE cases with loss/gain 
events of MGEs carrying genes potentially advantageous for environmental survival. Sub-
sampling within a single site in patient 5 demonstrated two distinct clades, separated by 26 
SNPs, defining isolates derived from opposing borders of the site (Figure 4a). The absence of 
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intervening variants suggested that in the sampled skin there had either been two separate 
acquisitions of the clade populations from a genetically closely related external population, or 
a single acquisition and a selective sweep removing intermediate genetic variants, establishing 
spatially and genetically distinct populations. Notably, a 27 kb plasmid carrying heavy metal 
resistance determinants was differentially distributed between the clades. In patient 1, a 
plasmid carrying the β-lactamase gene, blaZ, was present in 21 of 25 colonies (Figure 2a), 
thereby rendering the colonizing population differentially sensitive to penicillin. In contrast, 
no such examples were seen in controls, despite similarly diverse carriage populations.  
 
The impact of antimicrobials in shaping the colonizing populations was also evident in Patient 
1. All isolates from this patient contained two sequential point mutations in the gene encoding 
translation elongation factor G, fusA. The result being the amino acid change, L461K, which 
confers high level fusidic acid resistance (Chen et al. 2010). The clinical history in this 
individual confirmed the use of this agent 2 months prior to sampling, which had not 
improved symptoms relating to their eczema. The ancestor of this colonizing population is 
estimated to extensively predate this treatment (Figure 3), which would account for the lack 
of a therapeutic response, as colonization was by an already resistant population. 
 
In addition to clinical interventions, we detected evidence of selection linked to survival in the 
host. In the S. aureus isolated from patient 4 two distinct mutations (Tables S5/6) ablating the 
expression of agrA, a global virulence regulator (Fowler et al. 2004; Cheung et al. 2011), 
were identified; 1 colony contained a nonsense mutation, and 18 colonies contained a 
frameshift mutation (Figure 4b). The phylogenetic context of these isolates revealed they 
arose independently, and during the predicted period of colonization. The convergent 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 9 
evolution of mutations in this key regulator is evidence of a strong selective pressure 
favouring reduced virulence in this population.  
 
DISCUSSION  
Deep sequencing has allowed an unprecedented view of the micro-evolutionary changes 
occurring during carriage in AE with evidence of selection for specific strain backgrounds 
colonizing AE skin. In-depth analysis of within-host genetic variation revealed differences 
that impact both on the pathogenic potential of the bacterial cells and their response to 
common clinical interventions. 
  
Healthy nasal carriage controls exhibited a similar clonal population structure indicating the 
observed clonal expansion in AE was not a unique facet of the disease, but rather a reflection 
of the natural colonization dynamics of S. aureus. In this regard, AE affected skin represents 
an additional opportunistic niche for colonization, distinguished by an apparent selection for 
certain S. aureus lineages. A previous study of S. aureus strains from Korean AE patients did 
not find prevailing genotypes (Kim et al. 2009).  However the authors reported one third of 
the isolates belonged to CC1, the same lineage differentially prevailing in our cases. This 
clonal lineage has recently been reported for its prevalence in AE patients in association with 
Filaggrin mutations (Clausen et al. 2017). Nasal carriage studies by definition investigate 
niche-site colonization and repeatedly show CC30 and 45 as the dominant lineages (Melles et 
al. 2004; Monecke et al. 2009). CC30 was the most prevalent lineage in our controls, in 
agreement with these previous studies and more contemporaneously by (Fleury et al. 2017). 
These findings raise the question of whether there are lineage specific features making them 
more adept at colonization of the vastly differing cutaneous environments of the nasal versus 
inflamed eczema skin. This emphasizes an area where future studies must be directed.  
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The nose is often cited as the primary reservoir of S. aureus colonization associated with AE 
(Hoeger et al. 1992; Lomholt et al. 2005). Our study established evidence of self-
transmission, however in 5 of 9 cases nasal colonization was notably absent, suggesting the 
colonizing population was potentially derived from an extrinsic source. In these cases 
transmission could have arisen from a contact with a carrier, such as a family member or from 
the environment. Equally it is possible that the point prevalence sampling did not capture 
transitory nasal carriage, or that there was an un-sampled reservoir as the source of self-
transmission. An extended study assessing longitudinal colonization of individuals and their 
close contacts is needed to elucidate the origins of the flare-associated S. aureus population.  
 
In this study, 5 AE cases had carriage populations estimated to have diverged from a common 
ancestor more than 12 months previously (Figure 3). In 4 of these cases the predicted 
ancestral origins of the clonal colonizing population pre-dates the age of the child. This 
suggests that the origins of the diversity observed in these individual’s populations may have 
arisen during carriage within another host, with subsequent transmission of part of that 
population to the individual. Familial cross-transmission of S. aureus is likely to be highly 
relevant, and currently little is understood about this in the context of AE, although it has 
been shown that households are important reservoirs for transmission and diversification of S. 
aureus (Knox et al. 2015). In future, serially sampling AE patients and their family members 
would enable us to assess the impact that selective sweeps and transmission bottlenecks have 
on shaping the diversity we observe in AE colonization.  
 
From the most mature colonization populations we uncovered clear evidence of selection 
shaping the populations, providing insights into mechanisms of bacterial persistence, and 
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other potential origins of the clonally expanded populations in these individuals. Data from 
two AE cases revealed bacterial genetic responses linked with intracellular survival. The 
homoplastic mutations of agrA in patient 4 are strongly indicative of selection being exerted 
on the colonizing population. A recent in vitro study demonstrated that agr mutants are able 
to internalize and persist within keratinocytes subverting host clearance, with agr mutants 
being recovered from keratinocytes at a frequency of over 58% (Soong et al. 2015). 
Independent mutations in agrA suggest that intracellular colonization and survival may have 
contributed to the persistence of S. aureus in patient 4. It is worth noting that intracellular 
populations are less penetrable by antimicrobial therapy, and are therefore a potential cause of 
treatment failure. The fusA mutation in the S. aureus population in patient 1 who had previous 
exposure to fusidic acid, is associated with a small colony variant (SCV) phenotype 
(Norström et al. 2007).  SCVs are phenotypic sub-populations occurring within a parent strain 
which are slow growing and show increased propensity to persist within host cells (Sendi and 
Proctor 2009). Intracellular S. aureus has been reported in the context of both Darier’s disease 
and chronic rhinosinusitus as a cause of antimicrobial therapy failure (Eiff et al. 2001; Hayes 
et al. 2015). Thus we demonstrate two different mechanisms in separate cases that would 
support intracellular persistence and treatment resistance. 
 
These findings highlight the therapeutic challenges of effectively eradicating S. aureus 
colonization in AE. During colonization there are potentially unrecognized genetic 
adaptations rendering the population both insensitive and inaccessible to antimicrobial 
therapy, consequently prolonging pro-inflammatory interaction with the host. Longitudinal 
follow up of the colonizing population for assessment of diversity, evidence of adaptation and 
impact of therapies will advance our understanding of the relationship between S. aureus and 
disease activity. This is of particular relevance in children prone to repeated infective flares 
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where identifying and understanding genetic adaptation in the colonizing population may 
improve precision of treatment.  
 
MATERIALS AND METHODS  
 
Recruitment and sampling 
Prospective AE case and community control sampling studies received ethical approval from 
the Nottingham 1 – East Midlands Research Ethics Committee (14/EM/1299) and East of 
Scotland Research Ethics service (15/ES/0153) respectively. Studies were conducted in 
accordance with the principles of the Declaration of Helsinki. Written informed parental 
consent as well as child assent was obtained before participation.  
 
Cases were recruited at paediatric eczema clinics in Ninewells Hospital, Dundee, between 
February and October 2015. Community control samples were obtained from 306 school 
children in Tayside and North Fife between November 2015 and February 2016. Case study 
inclusion criteria were: age 0-8 years and dermatologist-diagnosed moderate to severe AE. 
Exclusionary criteria were: antimicrobials (systemic or topical) within the preceding 4 weeks, 
topical antiseptics within the preceding 2 weeks, or ultraviolet therapy (UV) within 3 months. 
Control study inclusion criteria: age 0-12 years. Samples obtained from control study 
participants with parent reported history of inflammatory skin disease, antibiotic therapy (<4 
weeks previously), antiseptic therapy (<2 weeks), UV (<3 months) were not utilised as 
comparators in this study. Controls were selected from this study collection on the basis of 
age proximity to cases, no history of atopy or antimicrobial usage as per case criteria. 
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All participants were examined by an experienced dermatologist and AE disease severity 
scored using EASI (Eczema Area Severity Index) (Hanifin et al. 2001). Clinical history was 
obtained from cases during clinic review, and in controls via a parental questionnaire. Cases 
were swabbed (Transtube Amies swab, Medical Wire, England) from 5 sites including a 
single nostril, 2 areas of inflamed eczema, and 2 separate areas of unaffected skin. Eczema 
sites were sub-sampled where a swab was taken from the lateral and medial border of the site, 
4 cm apart. Controls were sampled from a single nostril and antecubital fossa.   
 
Bacterial isolation 
Swabs were plated on Brilliance Staph 24 selective agar (Oxoid, UK) and incubated at 37oC 
for 24h. Selective enrichment was also undertaken with swabs being used to inoculate 3ml of 
Nutrient Broth with 7.5% NaCl (Oxoid, UK) grown statically at 37oC for 18h. 100µl of broth 
was plated on selective agar as described above. Colonies were then sub-cultured onto Brain 
Heart Infusion (BHI) agar (Sigma Aldrich, UK) and confirmed as S. aureus by PCR detection 
of species specific femB gene (Paterson et al. 2012).  
 
DNA extraction and whole genome sequencing 
Genomic DNA was extracted from overnight cultures of single colonies grown at 37oC using 
Masterpure Gram Positive DNA purification kit (Epicentre, UK) as per manufacturers 
protocol. DNA libraries were prepared using Nextera XT Library Preparation Kit (Illumina, 
UK) and quantified using Qubit High Sensitivity assay (LifeTechnologies, UK) and Agilent 
Bioanalyser (Agilent, UK). Libraries were normalized, pooled and sequenced as paired-end 
reads on a MiSeq Genome Sequencer (Illumina, UK).  
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Bioinformatic and statistical analyses  
Fastq files from MiSeq sequencing (Table S7) were assembled de novo with Velvet (Zerbino 
and Birney 2008). Multi-locus sequence types (MLST) were predicted from sequence reads 
using SRST2 (Inouye et al. 2014). To identify single nucleotide polymorphisms (SNPs) 
sequence reads were aligned to a reference genome of the same clonal complex (Table S8) 
using SMALT (http://www.sanger.ac.uk/science/tools/smalt-0). The default mapping 
parameters and SNP filtering were as previously described by (Hsu et al. 2015). Where an 
appropriate reference was unavailable a de novo assembly from the participants samples was 
used for mapping, typically this was the assembly with the lowest number of contigs derived 
from the highest number of reads. Accessory genome regions (Table S9) were identified in 
the reference chromosomes using ACT (Artemis Comparison Tool) (Carver et al. 2008) to 
compare pairwise BLASTN (Altschul et al. 1990) comparisons of reference genome 
sequences. Accessory regions were then masked from SNP alignments. The remaining core 
genome SNPs were individually curated by inspection of BAM files in Artemis to exclude 
false positives (Table S10), the subsequent SNPs were then used to construct maximum 
likelihood (ML) phylogenies with RAxML (Stamatakis 2006). Insertion/deletions (indels) 
were identified using GATK (https://software.broadinstitute.org/gatk/). Each participant’s 
reads were re-mapped to the de novo assembly, and GATK used to identify indels in 
comparison to the patient reference sequence. Indels were curated by manual inspection of 
BAM files in Artemis (Rutherford et al. 2000). 
 
The relative diversity in each participant colony population was calculated by dividing the 
number of core genome SNPs per sequenced colony per individual. Temporal calculation for 
the age of the S. aureus populations was based on half the maximum pairwise core SNP 
distance and base substitution rates derived from analysis of the major S. aureus lineages as 
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described by (Uhlemann et al. 2014). A rate of 1.6x10-6 SNPs/site/year was chosen as a 
median between published ranges. For each reference chromosome used an expected base 
substitution rate per month was calculated based on the size of their respective core genomes. 
Functional classification of genes was conducted on the MSSA476 reference genome (Holden 
et al. 2004), using the previously described classification scheme in Gram-positive organisms 
(Weinert et al. 2015). All comparative statistics were performed as two-tailed tests using R 
software version 3.3.1 (R Core Team 2016). 
 
Data access 
Short reads for all sequenced isolates have been submitted to the European Nucleotide 
Archive (ENA; http://www.ebi.ac.uk/ena/) under project accession PRJEB20148. 
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TABLES 
Phenotype Atopic eczema case  Nasal carriage control  
Total number of participants  9 18 
Age in years, mean (range) 1.4  (0.25-4) 6.6 (5-8) 
Sex  4Males/5Females 9Males/9Females 
EASI score, mean (range)* 24.4 (12.8-37) N/A 
Atopic disease 
Atopic eczema  9 0 
Asthma  0 0 
Hayfever 2  0 
Food allergy 3  0 
Other inflammatory skin disease  0 0 
 
Table 1: Participant characteristics of Atopic Eczema cases and healthy nasal carriage 
controls. N/A not applicable. * This range excludes patient 5 who had locally severe disease 
only.  
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FIGURE LEGENDS 
 
Figure 1. Genetic diversity of S. aureus strains associated with AE flares. The distribution 
of the clonal complex (CC) structure of S. aureus isolates from AE cases (n=9) and nasal 
carriage controls (n=18). In the single case where co-colonization (patient 8) was observed, 
both CCs identified in the colonizing population are represented. Skin and extra-nasal 
carriage was found in 4 AE cases (Table S2), of which 3 were carrying CC1 isolates at both 
sites, and 1 was carrying CC121 isolates (Table S3).  Skin only carriage isolates in AE cases 
(n=5) were distributed across clonal backgrounds (Tables S2/3).  
 
Figure 2. Clonal expansion and self-transmission in Patient 1 
(A) Maximum likelihood (ML) core SNPs tree illustrating genetic relationships of colonies 
across 3 body sites Body diagram shows sampling site, branch label coloring corresponds to 
site colony was obtained from. Perforated boxes indicate transmission between body sites. * 
Indicates where beta-lactamase carrying plasmid is absent.  Branch labels: E- eczema,(1/ 2 
lateral/ medial), U- unaffected , N- nose, C- colony number from site, ic/ -18 (pre- or post-
enrichment colony). Tree rooted using ST188 reference. Scale bar is approximately 1 SNP 
(not applicable to root branches with strikethrough). (B) Box plot comparing pairwise SNP 
difference between sequenced colonies from different body sites in a single patient.  
 
Figure 3. Estimated age of the colonizing populations 
Time point to the most recent common ancestor of the population is presented in months and 
is calculated from half of the maximum pairwise SNP distance observed in the sampled 
populations. Both colony populations within patient 8 are included.  
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Figure 4. Evidence of selection and genetic adaptation within the host  
(a) Evidence of plasmid dynamics and an evolutionary bottleneck. ML core SNPs tree 
illustrating genetic relationship of colonies from two spatially distinct positions in single 
eczema site. Branch label marked with a red arrow indicates point in phylogeny where a 
plasmid (backbone similar to SAP0194) carrying multiple metal resistance genes was gained 
in the S. aureus population. Tree rooted using MRSA252 reference. Branch labels: E1/ 3- 
lateral border, E2/4- medial border of single eczema site. SNP bar is indicated for scale (not 
applicable to root branches with strikethrough). (b) Convergent evolution of agrA mutants. 
ML core SNP tree of colonies from 5 body sites. Branch label marked with red arrows 
indicate the point in phylogeny where homoplastic mutations in agrA are predicted to have 
occurred. Tree rooted using MSSA476 reference. 
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